Drug intelligence / Profile preview

Allergyl

Development stage
Unknown
Lead developer
Nasaleze International
Administration
Intranasal
01

Overview

Allergyl is a nasal powder spray used for the prevention and relief of allergic rhinitis symptoms, including hay fever and allergies to dust mites or animal dander. It is composed of high-quality, natural cellulose powder of vegetable origin and peppermint powder. When administered intranasally, the powder reacts with the moisture on the nasal mucosa to form a thin, colorless, gel-like protective film. This physical layer acts as a mechanical barrier that traps airborne allergens before they can penetrate the nasal tissue and trigger an inflammatory response. As a drug-free, non-systemic treatment, Allergyl does not cause side effects such as drowsiness or dry mouth and is suitable for use by adults, children, and pregnant or breastfeeding women. It is distributed in the Austrian market by Germania Pharmazeutika.

Brand names
Allergyl
Other names
Allergyl Nasen-Schutzspraycellulose powderNasaleze

Beyond the preview

Go deeper on Allergyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allergyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call